NASDAQ:QNCX

Quince Therapeutics Stock Forecast

etoro logo Buy QNCX
*Your capital is at risk
$30.65
+0.450 (+1.49%)
At Close: Aug 10, 2026

Should you buy QNCX stock?

Last updated:

Based on market data through , StockInvest.us rates Quince Therapeutics, Inc. (QNCX) as a Strong Buy Candidate with a technical score of 5.25 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 58.23%
  • 3-month trend forecast Up 2.28%
  • Strong Buy Candidate 5.25
AI Analysis AI Analysis of QNCX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add QNCX to Watchlist?
Some Reasons Why To Add QNCX:
  • Strong return on equity of 1,823.5%
  • Highly efficient cash conversion (101% FCF/OCF ratio)
  • Beat earnings estimates in 2 of the last 4 quarters
PDF

Quince Therapeutics, Inc. stock upgraded to Strong Buy Candidate
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 28, 2026 Gain 58.23%

The Quince Therapeutics, Inc. stock price gained 1.49% on the last trading day (Monday, 10th Aug 2026), rising from $30.20 to $30.65. It has now gained 10 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.13% from a day low at $30.00 to a day high of $30.94. The price has risen in 10 of the last 10 days and is up by 71.71% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 thousand more shares were traded than the day before. In total, 34 thousand shares were bought and sold for approximately $1.03 million.

Given the current short-term trend, the stock is expected to rise 2.28% during the next 3 months and, with a 90% probability hold a price between $17.44 and $31.35 at the end of this 3-month period.

QNCX Signals & Forecast

Mostly positive signals in the chart today. The Quince Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $27.86 and $20.43. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has risen 82.99%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Quince Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Quince Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $24.00 and $23.03. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Quince Therapeutics, Inc. finds support just below today's level at $24.00. If this is broken, then the next support from accumulated volume will be at $23.03 and $23.00.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.94 between high and low, or 3.13%. For the last week, the stock has had daily average volatility of 6.97%.

The Quince Therapeutics, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs. Since the Quince Therapeutics, Inc. has been rising for 10 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $29.69 (-3.14%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 93 and this increases the risk substantially. There is a buy signal from a pivot bottom found 27 days ago.)

Trading Expectations (QNCX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Quince Therapeutics, Inc. to open at $30.53, and during the day (based on 14 day Average True Range), to move between $29.75 and $31.55, which gives a possible trading interval of +/-$1.80 (+/-6.04%) up or down from last closing price. If Quince Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.04% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $24.00, some $6.65 (21.70%) from the current price of $30.65, our system finds the risk reward attractive.

Is Quince Therapeutics, Inc. stock A Buy?

Quince Therapeutics, Inc. holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 5.250 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $30.53 ( 0.392%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

QNCX Performance

Trading levels for QNCX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.47 2.68%
R2 31.11 1.50%
R1 30.89 0.780%
Price 30.65
S1 30.17 -1.56%
S2 29.95 -2.29%
S3 29.59 -3.46%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 30.65
S1 24.00 -21.70%
S2 23.03 -24.86%
S3 23.00 -24.96%

FAQ

What is the symbol for Quince Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Quince Therapeutics, Inc. is QNCX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Quince Therapeutics, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Quince Therapeutics, Inc. (QNCX) as a Strong Buy Candidate with a technical score of 5.25 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation. Since the Buy signal began on Jul 28, 2026, the price has risen 58.23%. The current 3-month trend forecast projects a rise of 2.28%.

How to buy Quince Therapeutics, Inc. Stock?
Quince Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Quince Therapeutics, Inc. Stock.

What's the current price of Quince Therapeutics, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Quince Therapeutics, Inc. (QNCX) share was $30.65.

What is the 52-week high and low for Quince Therapeutics, Inc. Stock?
The 52-week high for Quince Therapeutics, Inc. Stock is $909.98 and the 52-week low is $15.23.

What is the market capitalization of Quince Therapeutics, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Quince Therapeutics, Inc. is 8.533M.

When is the next earnings date for Quince Therapeutics, Inc.?
The upcoming earnings date for Quince Therapeutics, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE